Reframing TACE–immunotherapy integration in unresectable HCC: from hypoxia to immunometabolic crosstalk

Simple item page
dc.contributor.authorVeerasatian T.
dc.contributor.authorRattanapitoon S.K.
dc.contributor.authorThanchonnang C.
dc.contributor.authorRattanapitoon N.K.
dc.contributor.correspondenceVeerasatian T.
dc.contributor.otherMahidol University
dc.date.accessioned2025-10-30T18:18:41Z
dc.date.available2025-10-30T18:18:41Z
dc.date.issued2025-01-01
dc.identifier.citationHepatology International (2025)
dc.identifier.doi10.1007/s12072-025-10945-w
dc.identifier.eissn19360541
dc.identifier.issn19360533
dc.identifier.scopus2-s2.0-105019604847
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/112819
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleReframing TACE–immunotherapy integration in unresectable HCC: from hypoxia to immunometabolic crosstalk
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105019604847&origin=inward
oaire.citation.titleHepatology International
oairecerif.author.affiliationMahidol University
oairecerif.author.affiliationFMC Medical Center
oairecerif.author.affiliationBuriram Hospital

Files

Collections

Scopus 2025